Marqeta (MQ) FT Partners FinTech Conference summary

Executive insights and recent performance

• Q3 saw strong EBITDA and 24% gross profit growth, though slightly below expectations due to delayed program launches averaging 70 days and fewer ramping programs, impacting Q4 guidance.

• Delays were mainly caused by increased regulatory scrutiny, doubling average launch times from 150 to 300 days in early 2024, with Q3 still 30-40% above historical norms.

• Some fintech customers are taking over components of their programs, slightly reducing gross profit but not posing significant ongoing risk.

• Focus remains on optimizing processes with bank partners to return to a 150-day launch cycle within a couple of quarters.

• Expense management improvements and international hiring have increased efficiency, supporting a path to at least $50 million EBITDA in 2025.

Regulatory and banking environment

• Heightened regulatory scrutiny has led to longer onboarding and approval processes, with banks requiring resubmission for changes like spend limits, causing multi-month delays.

• The company is working to adapt processes with banks to mitigate these delays and expects improvement in the next few quarters.

• Initial focus in 2024 was on minimizing disruption for existing customers, which has limited the impact of regulatory changes on current business.

Program launches and growth outlook

• Of 15 delayed programs, five launched in Q3, nine are on track for Q4, and one is expected in Q1 2025.

• Growth for Q4 is seen as a good indicator for 2025, with new program ramp delays pushing revenue contribution one to two quarters behind prior expectations.

• The steep ramp of new programs means launch delays have significant multi-quarter impacts on growth.